Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$35 Mln
P/E Ratio
--
P/B Ratio
--
Industry P/E
--
Debt to Equity
--
ROE
--
ROCE
--
Div. Yield
--
Book Value
--
EPS
--
CFO
$-42.83 Mln
EBITDA
$-66.33 Mln
Net Profit
$-86.08 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Zivo Bioscience Inc. Warrants (ZIVOW)
| -31.21 | -10.71 | -31.21 | 257.14 | 23.11 | -- | -- |
|
BSE Sensex*
| 1.72 | 3.50 | 4.95 | 8.90 | 11.18 | 21.04 | 11.14 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
|
|---|---|---|
|
Zivo Bioscience Inc. Warrants (ZIVOW)
| 4,303.36 | -94.81 |
|
S&P Small-Cap 600
| 7.01 | 13.89 |
|
BSE Sensex
| 8.10 | 18.74 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company... operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan. Address: 2125 Butterfield Drive, Troy, MI, United States, 48084 Read more
President, CEO & Chairman of the Board
Mr. John B. Payne
President, CEO & Chairman of the Board
Mr. John B. Payne
Headquarters
Troy, MI
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Zivo Bioscience Inc Warrants (ZIVOW) is $1.25 (NASDAQ) as of 02-Apr-2025 14:27 EDT. Zivo Bioscience Inc Warrants (ZIVOW) has given a return of 23.11% in the last 3 years.
Zivo Bioscience Inc Warrants (ZIVOW) has a market capitalisation of $ 35 Mln as on 02-Apr-2025. As per Value Research classification, it is a Small Cap company.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Zivo Bioscience Inc Warrants (ZIVOW) and enter the required number of quantities and click on buy to purchase the shares of Zivo Bioscience Inc Warrants (ZIVOW).
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan. Address: 2125 Butterfield Drive, Troy, MI, United States, 48084
The CEO & director of Mr. John B. Payne. is Zivo Bioscience Inc Warrants (ZIVOW), and CFO & Sr. VP is Mr. John B. Payne.
There is no promoter pledging in Zivo Bioscience Inc Warrants (ZIVOW).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|
| Zivo Bioscience Inc. Warrants (ZIVOW) | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
--
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Zivo Bioscience Inc Warrants (ZIVOW) was $0 Mln.
$1.07
(
